Chargement en cours...
Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement
Amyotrophic lateral sclerosis (ALS) is a clinically progressive neurodegenerative syndrome predominantly affecting motor neurons and their associated tracts. Riluzole and edaravone are the only FDA certified drugs for treating ALS. Over the past two decades, almost all clinical trials aiming to deve...
Enregistré dans:
| Publié dans: | Front Neurol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5626834/ https://ncbi.nlm.nih.gov/pubmed/29033893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2017.00521 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|